Language selection

Search

Details for: SANDOSTATIN

Company: NOVARTIS PHARMACEUTICALS CANADA INC

DIN DIN name Active Ingredient(s) Strength Dosage Form Route of Administration
02239323SANDOSTATIN LAROCTREOTIDE (OCTREOTIDE ACETATE)10 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
02239324SANDOSTATIN LAROCTREOTIDE (OCTREOTIDE ACETATE)20 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
02239325SANDOSTATIN LAROCTREOTIDE (OCTREOTIDE ACETATE)30 MG / VIALPOWDER FOR SUSPENSION, SUSTAINED-RELEASEINTRAMUSCULAR
00839191SANDOSTATINOCTREOTIDE (OCTREOTIDE ACETATE)50 MCG / MLSOLUTIONINTRAVENOUS
00839191SANDOSTATINOCTREOTIDE (OCTREOTIDE ACETATE)50 MCG / MLSOLUTIONSUBCUTANEOUS
00839205SANDOSTATINOCTREOTIDE (OCTREOTIDE ACETATE)100 MCG / MLSOLUTIONSUBCUTANEOUS
00839205SANDOSTATINOCTREOTIDE (OCTREOTIDE ACETATE)100 MCG / MLSOLUTIONINTRAVENOUS
Search Reported Side Effects Report a Side Effect

Consumer Information

The Consumer Information is not yet available in the Drug and Health Product Register. Try searching on the active ingredient(s) to find other similar products.

Date modified: